Choosing the right path in clinical development – as in life – is a huge challenge.  For small companies it can be the difference between success and failure, survival and implosion.  But divergent clinical data published in the last month on two apparently similar members of the Factor Xa inhibitor class demonstrate that the largest pharma companies can get it wrong too – and the consequences for them may be no less catastrophic.More

The Cambridge Partnership is the only professional services company in the UK exclusively dedicated to supporting companies in the biotechnology industry. We specialize in providing a “one-stop shop” for accountancy, company secretarial, IP management and admin services. The Cambridge Partnership was founded in 2012 to fill a gap. Running a biotechnology company has little …